focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 326.50
Bid: 326.00
Ask: 327.00
Change: 3.50 (1.08%)
Spread: 1.00 (0.307%)
Open: 323.50
High: 328.00
Low: 322.00
Prev. Close: 323.00
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

6 Nov 2020 07:00

RNS Number : 4469E
Morgan Advanced Materials PLC
06 November 2020
 

 

 

Press Release

Morgan Advanced Materials plc

06 November 2020

 

Q3 trading update

 

 

Our employees and operations

 

The health, safety and wellbeing of our employees is our top priority. We continue to operate our heightened safety measures such as social distancing and hygiene protocols in all of our facilities to ensure the safety of our employees and we continue to follow the advice of the relevant local governments. All of our plants are operating at this time.

 

 

Current trading

 

Sales for the nine months to 30 September 2020 were 9.8% lower for the Group, on an organic constant currency basis, compared to the same period last year. This reflects a 11.5% organic constant currency decline in the third quarter, an improvement from the 15.4% decline seen in the second quarter.

 

By business, the organic constant currency trends for the nine months to 30 September 2020 compared to the same period last year are as follows:

 

- Carbon & Technical Ceramics division sales were 6.3% lower, with growth in Seals & Bearings partially offsetting declines in Electrical Carbon and Technical Ceramics.

- Thermal Products division sales were 14.1% lower.

 

With respect to order trajectory, we have seen an improving performance since the position reported at the half year, with average daily order intake improving to a year on year decline of around 15% in August to October.

 

 

Mitigating actions

 

Throughout the downturn we have taken appropriate action to reduce costs, improve cash flow and increase liquidity. These include reductions to capital expenditure other than for vital health, safety and environmental matters, a temporary hiring freeze for all but the most critical roles, a curtailment of discretionary expenditure and temporary salary reductions for the Executive team and Board.

 

The restructuring programme announced in July is on track, with all of the major plant closures now announced, and key activities underway to structurally improve the efficiency of our businesses. This will reduce costs by £20 million per annum by 2022, with an anticipated cash cost of £30 million to deliver these savings.

 

 

Financial position

 

As at 30 September 2020 we had net debt (excluding lease liabilities) of £129 million, a £19 million improvement during the third quarter. We have significant liquidity, with cash and cash equivalents of £136 million and undrawn headroom of £119 million under our revolving credit facility, and no debt maturities until 2023.

 

 

Interim dividend

 

The Board recognises that dividends are an important part of the returns for shareholders. With the improving order trajectory since the half year and the strong financial position of the Group, the Board has declared an interim dividend for 2020 of 2.0 pence per share. The dividend will be payable on 11 December 2020 to shareholders on the register at the close of trading on 20 November 2020. The ex-dividend date is 19 November 2020.

 

 

Outlook

 

Subject to no significant change in Covid related operating restrictions, for the full year we anticipate the Group's organic constant currency sales decline to be in the range of 10-14%, with a return to organic constant currency sales growth anticipated from the second quarter of 2021.

 

 

Pete Raby, Chief Executive Officer, said:

 

 "We are pleased with our improving sales performance in the third quarter and order momentum going into the fourth quarter. With the sequential improvement in demand together with actions taken across the business, the Board is resuming an interim dividend. Whilst the current environment remains challenging, we are focussed on protecting our colleagues, serving our customers and preserving our strong financial position.

We are continuing our long-term investments to support the future growth of the business and our restructuring actions to improve efficiency. We are well positioned to emerge from this crisis stronger, growing quickly as our markets recover and expanding our margins as volumes return to more normal levels."

 

 

For further enquiries:

 

Pete Raby

Morgan Advanced Materials plc

01753 837 000

Peter Turner

 

Nina Coad

 

 

Brunswick

 

0207 404 5959 

 

 

This announcement contains inside information. The person responsible for the release of this announcement on behalf of Morgan Advanced Materials plc is Peter Turner, Chief Financial Officer

 

LEI: I4K14LL95N2PHDL7EG85

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKELFBBFLLFBL
Date   Source Headline
22nd Mar 20125:53 pmRNSDirector/PDMR Shareholding
22nd Mar 20125:52 pmRNSDirector/PDMR Shareholding
22nd Mar 20129:32 amRNSAnnual Financial Report
14th Mar 20123:34 pmRNSDirector/PDMR Shareholding
5th Mar 20125:54 pmRNSDirector/PDMR Shareholding
5th Mar 20122:48 pmRNSDirector/PDMR Shareholding
29th Feb 20125:10 pmRNSTotal Voting Rights
29th Feb 20124:14 pmRNSDirector/PDMR Shareholding
28th Feb 20125:53 pmRNSDirector/PDMR Shareholding
28th Feb 201210:51 amRNSHolding(s) in Company
24th Feb 201212:57 pmRNSTotal Voting Rights
22nd Feb 20123:29 pmRNSBlock Listing Application
15th Feb 20127:00 amRNSFinal Results
31st Jan 20129:47 amRNSTotal Voting Rights
23rd Jan 201210:08 amRNSDirector/PDMR Shareholding
16th Jan 20123:18 pmRNSDirector/PDMR Shareholding
12th Jan 20129:27 amRNSTotal Voting Rights
5th Jan 20121:03 pmRNSIssue of Equity
15th Dec 20113:37 pmRNSBlocklisting Interim Review
13th Dec 20115:54 pmRNSDirector/PDMR Shareholding
7th Dec 20111:58 pmRNSHolding(s) in Company
30th Nov 20113:26 pmRNSScrip Dividend Price
30th Nov 20111:16 pmRNSHolding(s) in Company
29th Nov 20114:06 pmRNSHolding(s) in Company
25th Nov 20119:41 amRNSDirector/PDMR Shareholding
14th Nov 20117:00 amRNSInterim Management Statement
18th Oct 20119:29 amRNSHolding(s) in Company
5th Oct 20115:50 pmRNSHolding(s) in Company
4th Oct 20119:57 amRNSDirector/PDMR Shareholding
12th Sep 201112:16 pmRNSDirector/PDMR Shareholding
31st Aug 20114:08 pmRNSHolding(s) in Company
24th Aug 201112:33 pmRNSDirector/PDMR Shareholding
11th Aug 20119:45 amRNSHalf Yearly Report
1st Aug 20119:35 amRNSTotal Voting Rights
20th Jul 20113:10 pmRNSDirector/PDMR Shareholding
13th Jul 20117:00 amRNSTrading Statement
8th Jul 20115:40 pmRNSDirector/PDMR Shareholding
8th Jul 20115:27 pmRNSTotal Voting Rights
1st Jul 201111:06 amRNSIssue of Equity
15th Jun 201112:03 pmRNSBlocklisting Interim Review
25th May 20119:57 amRNSScrip Dividend Price
11th May 20113:32 pmRNSResult of AGM
10th May 20117:00 amRNSInterim Management Statement
18th Apr 20112:59 pmRNSAnnual Information Update
8th Apr 20113:30 pmRNSDirector/PDMR Shareholding
8th Apr 201112:23 pmRNSHolding(s) in Company
8th Apr 201112:21 pmRNSDirector/PDMR Shareholding
6th Apr 20115:00 pmRNSDirector/PDMR Shareholding
31st Mar 20117:00 amRNSAnnual Financial Report
31st Mar 20117:00 amRNSCapital Markets Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.